TY - JOUR
T1 - Involvement of nitric oxide/reactive oxygen species signaling via 8-nitro-cGMP formation in 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells and rat cerebellar granule neurons
AU - Masuda, Kumiko
AU - Tsutsuki, Hiroyasu
AU - Kasamatsu, Shingo
AU - Ida, Tomoaki
AU - Takata, Tsuyoshi
AU - Sugiura, Kikuya
AU - Nishida, Motohiro
AU - Watanabe, Yasuo
AU - Sawa, Tomohiro
AU - Akaike, Takaaki
AU - Ihara, Hideshi
N1 - Funding Information:
This work was supported, in part, by Grants-in-Aid for Scientific Research B (to H.I. [ 16H04674 ], to T.S [ 15H03115 ]), Scientific Research A (to T.A [ 25253020 ]), Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area) (to T.A., Y.W. T.S [ 26111001 ]) and Grant-in-Aid for the Strategic Research Foundation at Private Universities (to Y.W [ S131101 ]) from the Ministry of Education, Sciences, Sports, and Technology (MEXT), Japan . This work was also supported, in part, by Grants-in-Aid from the Showa Pharmaceutical University for Young Scientists (to T.T [No. H28-2 ]).
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/1/15
Y1 - 2018/1/15
N2 - To investigate the role of nitric oxide (NO)/reactive oxygen species (ROS) redox signaling in Parkinson's disease-like neurotoxicity, we used 1-methyl-4-phenylpyridinium (MPP+) treatment (a model of Parkinson's disease). We show that MPP+-induced neurotoxicity was dependent on ROS from neuronal NO synthase (nNOS) in nNOS-expressing PC12 cells (NPC12 cells) and rat cerebellar granule neurons (CGNs). Following MPP+ treatment, we found production of 8-nitroguanosine 3′,5′-cyclic monophosphate (8-nitro-cGMP), a second messenger in the NO/ROS redox signaling pathway, in NPC12 cells and rat CGNs, that subsequently induced S-guanylation and activation of H-Ras. Additionally, following MPP+ treatment, extracellular signal-related kinase (ERK) phosphorylation was enhanced. Treatment with a mitogen-activated protein kinase (MAPK)/ERK kinase (MEK) inhibitor attenuated MPP+-induced ERK phosphorylation and neurotoxicity. In conclusion, we demonstrate for the first time that NO/ROS redox signaling via 8-nitro-cGMP is involved in MPP+-induced neurotoxicity and that 8-nitro-cGMP activates H-Ras/ERK signaling. Our results indicate a novel mechanism underlying MPP+-induced neurotoxicity, and therefore contribute novel insights to the mechanisms underlying Parkinson's disease.
AB - To investigate the role of nitric oxide (NO)/reactive oxygen species (ROS) redox signaling in Parkinson's disease-like neurotoxicity, we used 1-methyl-4-phenylpyridinium (MPP+) treatment (a model of Parkinson's disease). We show that MPP+-induced neurotoxicity was dependent on ROS from neuronal NO synthase (nNOS) in nNOS-expressing PC12 cells (NPC12 cells) and rat cerebellar granule neurons (CGNs). Following MPP+ treatment, we found production of 8-nitroguanosine 3′,5′-cyclic monophosphate (8-nitro-cGMP), a second messenger in the NO/ROS redox signaling pathway, in NPC12 cells and rat CGNs, that subsequently induced S-guanylation and activation of H-Ras. Additionally, following MPP+ treatment, extracellular signal-related kinase (ERK) phosphorylation was enhanced. Treatment with a mitogen-activated protein kinase (MAPK)/ERK kinase (MEK) inhibitor attenuated MPP+-induced ERK phosphorylation and neurotoxicity. In conclusion, we demonstrate for the first time that NO/ROS redox signaling via 8-nitro-cGMP is involved in MPP+-induced neurotoxicity and that 8-nitro-cGMP activates H-Ras/ERK signaling. Our results indicate a novel mechanism underlying MPP+-induced neurotoxicity, and therefore contribute novel insights to the mechanisms underlying Parkinson's disease.
KW - 8-nitro-cGMP
KW - H-Ras/ERK signaling
KW - MPP
KW - NO/ROS redox signaling
KW - Neurotoxicity
KW - nNOS
UR - http://www.scopus.com/inward/record.url?scp=85038810330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038810330&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2017.12.088
DO - 10.1016/j.bbrc.2017.12.088
M3 - Article
C2 - 29258821
AN - SCOPUS:85038810330
SN - 0006-291X
VL - 495
SP - 2165
EP - 2170
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -